While antimicrobial use and resistance (AUR) reporting has been voluntary through the National Health Safety Network (NHSN) for several years, Centers for Medicare & Medicaid Services (CMS) programs like Promoting Interoperability are beginning to require AUR reporting. The Joint Commission has been auditing components of antimicrobial stewardship (AMS) for several years and beginning in 2023, has begun to require AMS programs to track antimicrobial use using Days of Therapy (DOT) or AU reporting in surveys as a required element of performance.
In 2024, AUR submission will be part of the Medicare Promoting Interoperability Program and required to satisfy the Public Health and Clinical Data Exchange objective. Hospitals (including Critical Access Hospitals) must use an ONC-certified vendor to submit to avoid downward adjustment in reimbursements for Medicare beneficiaries.
On Thursday, November 16 at 12pm CST, SDAHO will host Antimicrobial Use and Resistance: Updates to NHSN and CMS Reporting Requirements for 2024 with presenter, Steve Mok, PharmD, MBA, BCPS, BCIDP, Manager of Pharmacy Services and Fellowship Director for Clinical Surveillance and Compliance with Wolters Kluwer. Click here for more info and to register.